1. Home
  2. JHI vs SRPT Comparison

JHI vs SRPT Comparison

Compare JHI & SRPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • JHI
  • SRPT
  • Stock Information
  • Founded
  • JHI 1971
  • SRPT 1980
  • Country
  • JHI United States
  • SRPT United States
  • Employees
  • JHI N/A
  • SRPT N/A
  • Industry
  • JHI Trusts Except Educational Religious and Charitable
  • SRPT Biotechnology: Pharmaceutical Preparations
  • Sector
  • JHI Finance
  • SRPT Health Care
  • Exchange
  • JHI Nasdaq
  • SRPT Nasdaq
  • Market Cap
  • JHI N/A
  • SRPT N/A
  • IPO Year
  • JHI N/A
  • SRPT 1997
  • Fundamental
  • Price
  • JHI $13.58
  • SRPT $43.26
  • Analyst Decision
  • JHI
  • SRPT Buy
  • Analyst Count
  • JHI 0
  • SRPT 23
  • Target Price
  • JHI N/A
  • SRPT $125.43
  • AVG Volume (30 Days)
  • JHI 29.5K
  • SRPT 4.2M
  • Earning Date
  • JHI 01-01-0001
  • SRPT 08-06-2025
  • Dividend Yield
  • JHI 6.80%
  • SRPT N/A
  • EPS Growth
  • JHI N/A
  • SRPT N/A
  • EPS
  • JHI 1.05
  • SRPT N/A
  • Revenue
  • JHI N/A
  • SRPT $2,233,371,000.00
  • Revenue This Year
  • JHI N/A
  • SRPT $37.38
  • Revenue Next Year
  • JHI N/A
  • SRPT $13.05
  • P/E Ratio
  • JHI $12.47
  • SRPT N/A
  • Revenue Growth
  • JHI N/A
  • SRPT 59.15
  • 52 Week Low
  • JHI $11.63
  • SRPT $34.10
  • 52 Week High
  • JHI $13.40
  • SRPT $173.25
  • Technical
  • Relative Strength Index (RSI)
  • JHI 66.18
  • SRPT 45.81
  • Support Level
  • JHI $13.29
  • SRPT $37.91
  • Resistance Level
  • JHI $13.65
  • SRPT $39.56
  • Average True Range (ATR)
  • JHI 0.10
  • SRPT 2.12
  • MACD
  • JHI 0.02
  • SRPT 1.35
  • Stochastic Oscillator
  • JHI 82.50
  • SRPT 69.12

About SRPT Sarepta Therapeutics Inc. (DE)

Sarepta Therapeutics Inc is a biotechnology company focused on treating rare, infectious, and other diseases. It targets a broad range of diseases while focusing on the rapid development of its drug candidates. Sarepta's involves proprietary RNA-targeted technology platforms to be used for developing novel pharmaceutical products to treat a broad range of diseases and address key unmet medical needs. The company uses third-party contractors to manufacture its product candidates. Majority of company's product candidates are at an early stage of development.

Share on Social Networks: